Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Behavioral & mental health software industry 360º synopsis, 2017-2030
2.1.1 Business trends
2.1.2 Component trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Behavioral & Mental Health Software Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017-2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of mental health disorders
3.3.1.2 Government funding and initiatives toward mental health services
3.3.2 Industry pitfalls & challenges
3.3.2.1 Data Privacy Concerns
3.4 Growth potential analysis
3.4.1 By component
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2021
3.7.1 Competitive matrix analysis
3.8 PESTEL analysis
Chapter 4 Behavioral & Mental Health Software Market, By Component
4.1 Key segment trends
4.2 Software
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.2.2 Web-based
4.2.2.1 Market size, by region, 2017-2030 (USD Million)
4.2.3 Cloud-based
4.2.3.1 Market size, by region, 2017-2030 (USD Million)
4.3 Services
4.3.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Behavioral & Mental Health Software Market, By Application
5.1 Key segment trends
5.2 Clinical
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.2 Electronic Health Record (EHR)
5.2.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.3 Health management
5.2.3.1 Market size, by region, 2017-2030 (USD Million)
5.2.4 Telehealth
5.2.4.1 Market size, by region, 2017-2030 (USD Million)
5.2.5 e- prescribing
5.2.5.1 Market size, by region, 2017-2030 (USD Million)
5.2.6 Clinical decision support
5.2.6.1 Market size, by region, 2017-2030 (USD Million)
5.2.7 Others
5.2.7.1 Market size, by region, 2017-2030 (USD Million)
5.3 Financial
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.4 Administrative
5.4.1 Market size, by region, 2017-2030 (USD Million)
Chapter 6 Behavioral & Mental Health Software Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, by region, 2017-2030 (USD Million)
6.3 Community clinics
6.3.1 Market size, by region, 2017-2030 (USD Million)
6.4 Private practices
6.4.1 Market size, by region, 2017-2030 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 7 Behavioral & Mental Health Software Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017-2030 (USD Million)
7.2.2 Market size, by component, 2017-2030 (USD Million)
7.2.2.1 Market size, by software, 2017-2030 (USD Million)
7.2.3 Market size, by application, 2017-2030 (USD Million)
7.2.3.1 Market size, by clinical, 2017-2030 (USD Million)
7.2.4 Market size, by end-use, 2017-2030 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by component, 2017-2030 (USD Million)
7.2.5.1.1 Market size, by software, 2017-2030 (USD Million)
7.2.5.2 Market size, by application, 2017-2030 (USD Million)
7.2.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.2.5.3 Market size, by end-use, 2017-2030 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by component, 2017-2030 (USD Million)
7.2.6.1.1 Market size, by software, 2017-2030 (USD Million)
7.2.6.2 Market size, by application, 2017-2030 (USD Million)
7.2.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.2.6.3 Market size, by end-use, 2017-2030 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017-2030 (USD Million)
7.3.2 Market size, by component, 2017-2030 (USD Million)
7.3.2.1 Market size, by software, 2017-2030 (USD Million)
7.3.3 Market size, by application, 2017-2030 (USD Million)
7.3.3.1 Market size, by clinical, 2017-2030 (USD Million)
7.3.4 Market size, by end-use, 2017-2030 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by component, 2017-2030 (USD Million)
7.3.5.1.1 Market size, by software, 2017-2030 (USD Million)
7.3.5.2 Market size, by application, 2017-2030 (USD Million)
7.3.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.3.5.3 Market size, by end-use, 2017-2030 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by component, 2017-2030 (USD Million)
7.3.6.1.1 Market size, by software, 2017-2030 (USD Million)
7.3.6.2 Market size, by application, 2017-2030 (USD Million)
7.3.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.3.6.3 Market size, by end-use, 2017-2030 (USD Million)
7.3.7 France
7.3.7.1 Market size, by component, 2017-2030 (USD Million)
7.3.7.1.1 Market size, by software, 2017-2030 (USD Million)
7.3.7.2 Market size, by application, 2017-2030 (USD Million)
7.3.7.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.3.7.3 Market size, by end-use, 2017-2030 (USD Million)
7.3.8 Italy
7.3.8.1 Market size, by component, 2017-2030 (USD Million)
7.3.8.1.1 Market size, by software, 2017-2030 (USD Million)
7.3.8.2 Market size, by application, 2017-2030 (USD Million)
7.3.8.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.3.8.3 Market size, by end-use, 2017-2030 (USD Million)
7.3.9 Spain
7.3.9.1 Market size, by component, 2017-2030 (USD Million)
7.3.9.1.1 Market size, by software, 2017-2030 (USD Million)
7.3.9.2 Market size, by application, 2017-2030 (USD Million)
7.3.9.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.3.9.3 Market size, by end-use, 2017-2030 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017-2030 (USD Million)
7.4.2 Market size, by component, 2017-2030 (USD Million)
7.4.2.1 Market size, by software, 2017-2030 (USD Million)
7.4.3 Market size, by application, 2017-2030 (USD Million)
7.4.3.1 Market size, by clinical, 2017-2030 (USD Million)
7.4.4 Market size, by end-use, 2017-2030 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by component, 2017-2030 (USD Million)
7.4.5.1.1 Market size, by software, 2017-2030 (USD Million)
7.4.5.2 Market size, by application, 2017-2030 (USD Million)
7.4.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.4.5.3 Market size, by end-use, 2017-2030 (USD Million)
7.4.6 China
7.4.6.1 Market size, by component, 2017-2030 (USD Million)
7.4.6.1.1 Market size, by software, 2017-2030 (USD Million)
7.4.6.2 Market size, by application, 2017-2030 (USD Million)
7.4.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.4.6.3 Market size, by end-use, 2017-2030 (USD Million)
7.4.7 India
7.4.7.1 Market size, by component, 2017-2030 (USD Million)
7.4.7.1.1 Market size, by software, 2017-2030 (USD Million)
7.4.7.2 Market size, by application, 2017-2030 (USD Million)
7.4.7.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.4.7.3 Market size, by end-use, 2017-2030 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by component, 2017-2030 (USD Million)
7.4.8.1.1 Market size, by software, 2017-2030 (USD Million)
7.4.8.2 Market size, by application, 2017-2030 (USD Million)
7.4.8.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.4.8.3 Market size, by end-use, 2017-2030 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017-2030 (USD Million)
7.5.2 Market size, by component, 2017-2030 (USD Million)
7.5.2.1 Market size, by software, 2017-2030 (USD Million)
7.5.3 Market size, by application, 2017-2030 (USD Million)
7.5.3.1 Market size, by clinical, 2017-2030 (USD Million)
7.5.4 Market size, by end-use, 2017-2030 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by component, 2017-2030 (USD Million)
7.5.5.1.1 Market size, by software, 2017-2030 (USD Million)
7.5.5.2 Market size, by application, 2017-2030 (USD Million)
7.5.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.5.5.3 Market size, by end-use, 2017-2030 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by component, 2017-2030 (USD Million)
7.5.6.1.1 Market size, by software, 2017-2030 (USD Million)
7.5.6.2 Market size, by application, 2017-2030 (USD Million)
7.5.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.5.6.3 Market size, by end-use, 2017-2030 (USD Million)
7.6 Middle East and Africa
7.6.1 Market size, by country, 2017-2030 (USD Million)
7.6.2 Market size, by component, 2017-2030 (USD Million)
7.6.2.1 Market size, by software, 2017-2030 (USD Million)
7.6.3 Market size, by application, 2017-2030 (USD Million)
7.6.3.1 Market size, by clinical, 2017-2030 (USD Million)
7.6.4 Market size, by end-use, 2017-2030 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by component, 2017-2030 (USD Million)
7.6.5.1.1 Market size, by software, 2017-2030 (USD Million)
7.6.5.2 Market size, by application, 2017-2030 (USD Million)
7.6.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.6.5.3 Market size, by end-use, 2017-2030 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by component, 2017-2030 (USD Million)
7.6.6.1.1 Market size, by software, 2017-2030 (USD Million)
7.6.6.2 Market size, by application, 2017-2030 (USD Million)
7.6.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
7.6.6.3 Market size, by end-use, 2017-2030 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Advanced Data Systems Corporation
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 SWOT analysis
8.3 AdvancedMD, Inc.
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 American Well
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 SWOT analysis
8.5 Netsmart Technologies, Inc.
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 NXGN Management, LLC
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 SWOT analysis
8.7 Meditab
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Therapy Brands.
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 SWOT analysis
8.9 TherapyNotes, LLC.
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Qualifacts Systems, Inc.
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Valant
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 SWOT analysis
8.12 Teladoc Health Inc
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 SWOT analysis
8.13 Ontrak Inc
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 SWOT analysis
